Nemaura Medical (NASDAQ: NMRD)
Nemaura Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nemaura Medical Company Info
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
News & Analysis
Why Micro Cap Nemaura Medical Crashed 39.5% Today
The clinical-stage upstart is raising money via a stock offering that dilutes existing investors.
Why Micro Cap Nemaura Medical Skyrocketed 32% Yesterday
The clinical-stage upstart is making progress in advancing a new type of glucose monitor to market.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.